메뉴 건너뛰기




Volumn 1135, Issue , 2014, Pages 331-341

Investigating the role of perlecan domain v in post-ischemic cerebral angiogenesis

Author keywords

Angiogenesis; Domain V; Ischemia; Perlecan

Indexed keywords

GELATINASE B; MATRIX PROTEIN; PERLECAN; PERLECAN DOMAIN V; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 84934441031     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-320-7_27     Document Type: Article
Times cited : (11)

References (38)
  • 1
    • 84896100933 scopus 로고    scopus 로고
    • American Stroke Association
    • American Stroke Association (2013). www. strokeassociation.org
    • , vol.2013
  • 2
    • 84877275312 scopus 로고    scopus 로고
    • Neuronal restoration following ischemic stroke: Influences, barriers, and therapeutic potential
    • Kahle M, Bix G (2013) Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil Neural Repair 27(5):469-478
    • (2013) Neurorehabil Neural Repair , vol.27 , Issue.5 , pp. 469-478
    • Kahle, M.1    Bix, G.2
  • 3
    • 62949100418 scopus 로고    scopus 로고
    • Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development
    • Kim H, Pawlikowska L, Chen Y, Su H, Yang G, Young W (2009) Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke 40:S95-S97
    • (2009) Stroke , vol.40
    • Kim, H.1    Pawlikowska, L.2    Chen, Y.3    Su, H.4    Yang, G.5    Young, W.6
  • 4
    • 66849142360 scopus 로고    scopus 로고
    • 4.5 hours: The new time window for tissue plasminogen activator in stroke
    • Davis S, Donnan G (2009) 4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke 40:2266-2267
    • (2009) Stroke , vol.40 , pp. 2266-2267
    • Davis, S.1    Donnan, G.2
  • 5
    • 84871919598 scopus 로고    scopus 로고
    • Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
    • Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma P (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 698:6-18
    • (2013) Eur J Pharmacol , vol.698 , pp. 6-18
    • Mehta, A.1    Prabhakar, M.2    Kumar, P.3    Deshmukh, R.4    Sharma, P.5
  • 6
    • 80051710005 scopus 로고    scopus 로고
    • Cellular mechanism of neurovascular damage and repair after stroke
    • Arai K, Lok J, Guo S, Hayakawa K, Xing C, Lo E (2011) Cellular mechanism of neurovascular damage and repair after stroke. J Child Neurol 26(9):1193-1198
    • (2011) J Child Neurol , vol.26 , Issue.9 , pp. 1193-1198
    • Arai, K.1    Lok, J.2    Guo, S.3    Hayakawa, K.4    Xing, C.5    Lo, E.6
  • 7
    • 84870623831 scopus 로고    scopus 로고
    • Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke
    • Demir R, Ulvi H, Ozel L, Ozdemir G, Guzelcik M, Aygul R (2012) Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke. Acta Neurol Belg 112:351-356
    • (2012) Acta Neurol Belg , vol.112 , pp. 351-356
    • Demir, R.1    Ulvi, H.2    Ozel, L.3    Ozdemir, G.4    Guzelcik, M.5    Aygul, R.6
  • 8
    • 78650699283 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 as a marker for acute ischemic stroke: A systemic review
    • Ramos-Fernandez M, Bellolio M, Stead L (2011) Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systemic review. J Stroke Cerebrovasc Dis 20(1):47-54
    • (2011) J Stroke Cerebrovasc Dis , vol.20 , Issue.1 , pp. 47-54
    • Ramos-Fernandez, M.1    Bellolio, M.2    Stead, L.3
  • 9
    • 0036195260 scopus 로고    scopus 로고
    • Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats
    • Sumii T, Lo E (2002) Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33:831-836
    • (2002) Stroke , vol.33 , pp. 831-836
    • Sumii, T.1    Lo, E.2
  • 10
    • 0041829250 scopus 로고    scopus 로고
    • Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies
    • Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34:2165-2170
    • (2003) Stroke , vol.34 , pp. 2165-2170
    • Horstmann, S.1    Kalb, P.2    Koziol, J.3    Gardner, H.4    Wagner, S.5
  • 11
    • 84875496877 scopus 로고    scopus 로고
    • Perlecan domain v therapy in stroke: A beacon of hope?
    • Bix G (2013) Perlecan domain V therapy in stroke: a beacon of hope? ACS Chem Neurosci 4(3):370-374
    • (2013) ACS Chem Neurosci , vol.4 , Issue.3 , pp. 370-374
    • Bix, G.1
  • 12
    • 34547690928 scopus 로고    scopus 로고
    • Therapeutic angiogenesis for brain ischemia: A brief review
    • Fan Y, Yang G-Y (2007) Therapeutic angiogenesis for brain ischemia: a brief review. J Neuroimmune Pharmacol 2:284-289
    • (2007) J Neuroimmune Pharmacol , vol.2 , pp. 284-289
    • Fan, Y.1    Yang, G.-Y.2
  • 13
    • 0038805170 scopus 로고    scopus 로고
    • Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis
    • Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown A, Iozzo R (2003) Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 278(19): 17491-17499
    • (2003) J Biol Chem , vol.278 , Issue.19 , pp. 17491-17499
    • Mongiat, M.1    Fu, J.2    Oldershaw, R.3    Greenhalgh, R.4    Gown, A.5    Iozzo, R.6
  • 16
    • 4043063680 scopus 로고    scopus 로고
    • The role of perlecan in arterial injury and angiogenesis
    • Segev A, Nili N, Strauss B (2004) The role of perlecan in arterial injury and angiogenesis. Cardiovasc Res 63:603-610
    • (2004) Cardiovasc Res , vol.63 , pp. 603-610
    • Segev, A.1    Nili, N.2    Strauss, B.3
  • 18
    • 67649367545 scopus 로고    scopus 로고
    • Perlecan regulates developmental angiogenesis by modulating to VEGF-VEGFR2 axis
    • Zoeller J, Whitelock J, Iozzo R (2009) Perlecan regulates developmental angiogenesis by modulating to VEGF-VEGFR2 axis. Matrix Biol 28:284-291
    • (2009) Matrix Biol , vol.28 , pp. 284-291
    • Zoeller, J.1    Whitelock, J.2    Iozzo, R.3
  • 19
    • 42949109152 scopus 로고    scopus 로고
    • Novel interactions of perlecan: Unraveling perlecan's role in angiogenesis
    • Bix G, Iozzo R (2008) Novel interactions of perlecan: unraveling perlecan's role in angiogenesis. Microsc Res Tech 71:339-348
    • (2008) Microsc Res Tech , vol.71 , pp. 339-348
    • Bix, G.1    Iozzo, R.2
  • 20
    • 1842471192 scopus 로고    scopus 로고
    • Focal cerebral ischemia induces active proteases that degrade microvascular matrix
    • Fukuda S, Fini C, Mabuchi T, Koziol J, Eggleston L, de Zoppo G (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35:998-1004
    • (2004) Stroke , vol.35 , pp. 998-1004
    • Fukuda, S.1    Fini, C.2    Mabuchi, T.3    Koziol, J.4    Eggleston, L.5    De Zoppo, G.6
  • 21
    • 14844299756 scopus 로고    scopus 로고
    • BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan
    • Gonzalez E, Reed C, Bix G, Fu J, Zhang Y, Gopalakrishnan B, Greenspan D, Iozzo R (2005) BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 280(8): 7080-7087
    • (2005) J Biol Chem , vol.280 , Issue.8 , pp. 7080-7087
    • Gonzalez, E.1    Reed, C.2    Bix, G.3    Fu, J.4    Zhang, Y.5    Gopalakrishnan, B.6    Greenspan, D.7    Iozzo, R.8
  • 23
    • 79960400832 scopus 로고    scopus 로고
    • Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): A duel receptor antagonism
    • Goyal A, Pal N, Concannon M, Paul M, Doran M, Poluzzi C, Sekiguchi K, Whitelock J, Neill T, Iozzo R (2011) Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a duel receptor antagonism. J Biol Chem 286(29): 25947-25962
    • (2011) J Biol Chem , vol.286 , Issue.29 , pp. 25947-25962
    • Goyal, A.1    Pal, N.2    Concannon, M.3    Paul, M.4    Doran, M.5    Poluzzi, C.6    Sekiguchi, K.7    Whitelock, J.8    Neill, T.9    Iozzo, R.10
  • 24
    • 84877710796 scopus 로고    scopus 로고
    • Endorepellin LG 1/2 domains bind Ig3-5 of VEGFR2 and block proangiogenic signaling by VEGFA in endothelial cells
    • Willis C, Poluzzi C, Mongiat M, Iozzo R (2013) Endorepellin LG 1/2 domains bind Ig3-5 of VEGFR2 and block proangiogenic signaling by VEGFA in endothelial cells. FEBS J 280(10):2271-2284
    • (2013) FEBS J , vol.280 , Issue.10 , pp. 2271-2284
    • Willis, C.1    Poluzzi, C.2    Mongiat, M.3    Iozzo, R.4
  • 25
    • 0025008824 scopus 로고
    • Immunostaining of human brain capillaries by antibodies to very late antigens
    • McGeer P, Zhu S, Dedhar S (1990) Immunostaining of human brain capillaries by antibodies to very late antigens. J Neuroimmunol 26(3):218-231
    • (1990) J Neuroimmunol , vol.26 , Issue.3 , pp. 218-231
    • McGeer, P.1    Zhu, S.2    Dedhar, S.3
  • 26
    • 38149075382 scopus 로고    scopus 로고
    • Responses to endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit
    • Milner R, Hung S, Wang X, Berg G, Spatz M, del Zoppo G (2007) Responses to endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke 39:191-197
    • (2007) Stroke , vol.39 , pp. 191-197
    • Milner, R.1    Hung, S.2    Wang, X.3    Berg, G.4    Spatz, M.5    Del Zoppo, G.6
  • 28
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • Ferrera N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669-676
    • (2003) Nat Med , vol.9 , Issue.6 , pp. 669-676
    • Ferrera, N.1    Gerber, H.-P.2    Lecouter, J.3
  • 29
    • 85047694286 scopus 로고    scopus 로고
    • VEGF: A critical player in neurodegeneration
    • Storkebaum E, Carmeliet P (2004) VEGF: a critical player in neurodegeneration. J Clin Invest 113:14-18
    • (2004) J Clin Invest , vol.113 , pp. 14-18
    • Storkebaum, E.1    Carmeliet, P.2
  • 30
    • 84866460601 scopus 로고    scopus 로고
    • Perlecan domain v induces VEGF secretion in brain endothelial cells through integrin αβ51 and ERK- dependent signaling pathways
    • Clarke D, Al Ahmad A, Lee B, Parham C, Auckland L, Fertala A, Kahle M, Shaw C, Roberts J, Bix G (2012) Perlecan domain V induces VEGF secretion in brain endothelial cells through integrin αβ51 and ERK- dependent signaling pathways. PLoS One 7(9):e45257
    • (2012) PLoS One , vol.7 , Issue.9
    • Clarke, D.1    Al Ahmad, A.2    Lee, B.3    Parham, C.4    Auckland, L.5    Fertala, A.6    Kahle, M.7    Shaw, C.8    Roberts, J.9    Bix, G.10
  • 31
    • 80054805066 scopus 로고    scopus 로고
    • Oxygen-glucose deprivation and interleukin-1α trigger the release of perlecan LG3 by cells of neurovascular unit
    • Saini M, Pinteaux E, Lee B, Bix G (2011) Oxygen-glucose deprivation and interleukin-1α trigger the release of perlecan LG3 by cells of neurovascular unit. J Neurochem 119:760-771
    • (2011) J Neurochem , vol.119 , pp. 760-771
    • Saini, M.1    Pinteaux, E.2    Lee, B.3    Bix, G.4
  • 32
    • 84856617377 scopus 로고    scopus 로고
    • Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons
    • Saini M, Bix G (2012) Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons. Brain Res 1438:65-74
    • (2012) Brain Res , vol.1438 , pp. 65-74
    • Saini, M.1    Bix, G.2
  • 33
    • 84866148470 scopus 로고    scopus 로고
    • Perlecan and the blood-brain barrier: Beneficial proteolysis?
    • Roberts J, Kahle M, Bix G (2012) Perlecan and the blood-brain barrier: beneficial proteolysis? Front Pharmacol 3:155
    • (2012) Front Pharmacol , vol.3 , pp. 155
    • Roberts, J.1    Kahle, M.2    Bix, G.3
  • 34
    • 80053561988 scopus 로고    scopus 로고
    • Perlecan domain v modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release
    • Al Ahmad A, Lee B, Saini M, Bix G (2011) Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release. Glia 59:1822-1840
    • (2011) Glia , vol.59 , pp. 1822-1840
    • Al Ahmad, A.1    Lee, B.2    Saini, M.3    Bix, G.4
  • 35
    • 0031936486 scopus 로고    scopus 로고
    • Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection
    • Yang R, Bunting S, Ko A, Keyt B, Modi N, Zioncheck T, Ferrara N, Jin H (1998) Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharmacol Exp Ther 284(1):103-110
    • (1998) J Pharmacol Exp Ther , vol.284 , Issue.1 , pp. 103-110
    • Yang, R.1    Bunting, S.2    Ko, A.3    Keyt, B.4    Modi, N.5    Zioncheck, T.6    Ferrara, N.7    Jin, H.8
  • 36
    • 0031984842 scopus 로고    scopus 로고
    • Platelet-activating factor receptor stimulation disrupts neuronal migration in vitro
    • Bix G, Clark G (1998) Platelet-activating factor receptor stimulation disrupts neuronal migration in vitro. J Neurosci 18:307-318
    • (1998) J Neurosci , vol.18 , pp. 307-318
    • Bix, G.1    Clark, G.2
  • 37
    • 0027869687 scopus 로고
    • Cloned mouse cerebrovascular endothelial cells that maintain their differentiation markers for factor VIII, low density lipoprotein, and angiotensin- converting enzyme
    • Sapatino B, Welsh C, Smith C, Bebo B, Linthicum D (1993) Cloned mouse cerebrovascular endothelial cells that maintain their differentiation markers for factor VIII, low density lipoprotein, and angiotensin- converting enzyme. In Vitro Cell Dev Biol 29A:923-928
    • (1993) Vitro Cell Dev Biol , vol.29 A , pp. 923-928
    • Sapatino, B.1    Welsh, C.2    Smith, C.3    Bebo, B.4    Linthicum, D.5
  • 38
    • 48149105146 scopus 로고    scopus 로고
    • Fibroblast-derived 3D matrix differentially conditions the growth and drug-responsiveness of human cancer cells
    • Serebriskii I, Castello-Cros R, Lamb A, Golemis E (2008) Fibroblast-derived 3D matrix differentially conditions the growth and drug-responsiveness of human cancer cells. Matrix Biol 27:573-578
    • (2008) Matrix Biol , vol.27 , pp. 573-578
    • Serebriskii, I.1    Castello-Cros, R.2    Lamb, A.3    Golemis, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.